Current role
Shell Companies · Financial Services
Board Member
2025-09-24–present
Myron W. Shulgan
Board Member
Drugs Made In America Acquisition II Corp. (DMII)Equibles does not estimate personal net worth.
Get an email with a short summary when Drugs Made In America Acquisition II Corp. publishes a filing, an earnings call transcript or a press release.
Get DMII alertsAbout Myron W. Shulgan
Myron W. Shulgan is recorded as Board Member at Drugs Made In America Acquisition II Corp. (DMII) since September 24, 2025. Drugs Made In America Acquisition II Corp. reported in an 8-K filed September 29, 2025 that Myron W. Shulgan was appointed director, effective September 24, 2025. Drugs Made In America Acquisition II Corp. is classified in the Shell Companies industry within the Financial Services sector. Other leadership on record at Drugs Made In America Acquisition II Corp. includes Roger Bendelac (CEO), Saleem Elmasri (CFO and Chief Accounting Officer), Catherine Do (Board Member) and 1 other.
“On September 24, 2025, and in connection with the IPO, Catherine Do, G. Sridhar Prasad and Myron W. Shulgan were appointed to the board of directors of the Company (the "Board").”
Affiliation history
-
Current
2025-09-24–present
Company network
Leadership on record at Drugs Made In America Acquisition II Corp.
- Roger Bendelac CEO
- Saleem Elmasri CFO, Chief Accounting Officer
- Catherine Do Board Member
- G. Sridhar Prasad Board Member